1,163
Views
1
CrossRef citations to date
0
Altmetric
Articles

Crosstalk of proteins, miRNAs involved in metastatic and epithelial–mesenchymal transition pathways

, &
Pages 323-346 | Received 05 Jun 2016, Accepted 30 Oct 2016, Published online: 01 Dec 2016

References

  • Achison M, Elton CM, Hargreaves PG, Knight CG, Barnes MJ, Farndale RW. 2001. Integrin-independent tyrosine phosphorylation of p125(fak) in human platelets stimulated by collagen. J Biol Chem. 276:3167–3174. doi: 10.1074/jbc.M007186200
  • Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA. 2009. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J clin invest. 119(6):1438–1449. doi: 10.1172/JCI38019
  • Altuvia Y, Landgraf P, Lithwick G, Elefant N, Pfeffer S, Aravin A, Brownstein MJ, Tuschl T, Margalit H. 2005. Clustering and conservation patterns of human microRNAs. Nucleic Acids Res. 33:2697–2706. doi: 10.1093/nar/gki567
  • Ansieau S, Bastid J, Doreau A, Morel AP, Bouchet BP, Thomas C, Fauvet F, Puisieux I, Doglioni C, Piccinin S, Maestro R. 2008. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell. 14(1):79–89. doi: 10.1016/j.ccr.2008.06.005
  • Ambros V. 2004. The functions of animal microRNA. Nature. 431:350–355. doi: 10.1038/nature02871
  • Andl CD, McCowan KM, Allison GL, Rustgi AK. 2010. Cathepsin B is the driving force of esophageal cell invasion in a fibroblast-dependent manner. Neoplasia. 12:485–498. doi: 10.1593/neo.10216
  • Arya M, Patel H, McGURK C, Tatoud R, Klocker H, Masters J, Williamson M. 2004. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis. J Exp Therap Oncol. 4:291–303.
  • Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S, Allgayer H. 2008. MicroRNA-21 (miR-21)post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene. 2:72128–72136.
  • Bae YK, Kim A, Kim MK, Choi JE, Kang SH, Lee SJ. 2013. Fibronectin expression in carcinoma cells correlates with tumor aggressiveness and poor clinical outcome in patients with invasive breast cancer. Hum Pathol. 44:2028–2037. doi: 10.1016/j.humpath.2013.03.006
  • Barbera MJ, Puig I, Domínguez D, Julien-Grille S, Guaita-Esteruelas S, Peiro S, Baulida J, Francí C, Dedhar S, Larue L, de Herreros AG. 2004. Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells. Oncogene. 23(44):7345–7354. doi: 10.1038/sj.onc.1207990
  • Barbieri MA, Kohn AD, Roth RA, Stahl PD. 1998. Protein kinase B/akt and Rab5 mediate Ras activation of endocytosis. J Biol Chem. 273:19367–19370. doi: 10.1074/jbc.273.31.19367
  • Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116:281–297. doi: 10.1016/S0092-8674(04)00045-5
  • Bartel DP. 2009. MicroRNAs: target recognition and regulatory functions. Cell. 136:215–233. doi: 10.1016/j.cell.2009.01.002
  • Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J, Garcia De Herreros A. 2000. The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2:84–89. doi: 10.1038/35000034
  • Baum B, Settleman J, Quinlan MP. 2008. Transitions between epithelial and mesenchymal states in development and disease. Semin Cell Dev Biol. 19:294–308. doi: 10.1016/j.semcdb.2008.02.001
  • Bellacosa A, Franke TF, Gonzalez-Portal ME, Datta K, Taguchi T, Gardner J, Cheng JQ, Testa JR, Tsichlis PN. 1993. Structure, expression and chromosomal mapping of c-akt: relationship to v-akt and its implications. Oncogene. 8(3):745–754.
  • Bellacosa A, Testa JR, Staal SP, Tsichlis PN. 1991. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science. 254(5029):274–277. doi: 10.1126/science.1833819
  • Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, Barad O, Barzilai A, Einat P, Einav U, Meiri E, et al. 2005. Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet. 37:766–770. doi: 10.1038/ng1590
  • Berx G, Becker KF, Hofler H, van Roy F. 1998. Mutations of the human E-cadherin (CDH1) gene. Hum Mutat. 12:226–237. doi: 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D
  • Birchmeier W, Behrens J. 1994. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta. 1198:11–26.
  • Boyer B, Valles AM, Edme N. 2000. Induction and regulation of epithelial–mesenchymal transitions. Biochem Pharmacol. 60:1091–1099. doi: 10.1016/S0006-2952(00)00427-5
  • Boyer B, Valles AM, Thiery JP. 1996. Model systems of Epithelium Mesenchyme transitions. Cells Tissues Organs. 156(3):227–239. doi: 10.1159/000147849
  • Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T. 2005. Migrating cancer stem cells–an integrated concept of malignant tumour progression. Nat Rev Cancer. 5(9):744–749. doi: 10.1038/nrc1694
  • Britt DE, Yang DF, Yang DQ, Flanagan D, Callanan H, Lim YP, Lin SH, Hixson DC. 2004. Identification of a novel protein, LYRIC, localized to tight junctions of polarized epithelial cells. Exp cell Res. 300(1):134–148. doi: 10.1016/j.yexcr.2004.06.026
  • Brugnera E, Haney C, Grimsley M, Lu SF, Walk AC, Tosello-Trampont IG, Macara HM, Fink GR, Ravichandra KS. 2002. Unconventional Rac-GEF activity is mediated through the Dock180-ELMO complex. Nat Cell Biol. 4, 574–582.
  • Bugge TH, Antalis TM, Wu Q. 2009. Type II transmembrane serine proteases. J Biol Chem. 284:23177–23181. doi: 10.1074/jbc.R109.021006
  • Buijs JT, Henriquez NV, van Overveld PGM, van der Horst G, Que I, Schwaninger R, Rentsch C, ten Dijke P, Cleton-Jansen A-M, Driouch K, et al. 2007. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer. Cancer Res. 67:8742–8751. doi: 10.1158/0008-5472.CAN-06-2490
  • Buijs JT, van der Horst G, van den Hoogen C, Cheung H, de Rooij B, Kroon J, Petersen M, van Overveld PGM, Pelger RCM, van der Pluijm G. 2012. The BMP2/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formation. Oncogene. 31:2164–2174. doi: 10.1038/onc.2011.400
  • Burden RE, Gormley JA, Kuehn D, Ward C, Kwok HF, Gazdoiu M, McClurg A, Jaquin TJ, Johnston JA, Scott CJ, Olwill SA. 2012. Inhibition of cathepsin S by Fsn0503 enhances the efficacy of chemotherapy in colorectal carcinomas. Biochimie. 94:487–493. doi: 10.1016/j.biochi.2011.08.017
  • Cabeen MT, Jacobs-Wagner C. 2010. The bacterial cytoskeleton. Annu Rev Genet. 44:365–392. doi: 10.1146/annurev-genet-102108-134845
  • Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F, Nieto MA. 2000. The transcription factor snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol. 2:76–83. doi: 10.1038/35000025
  • Carmeliet P, Jain RK. 2011. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov. 10:417–427. doi: 10.1038/nrd3455
  • Castillo SDM. 2012. The SOX family of genes in cancer development: biological relevance and opportunities for therapy. Expert Opin Therap Target. 16:903–919. doi: 10.1517/14728222.2012.709239
  • Chaffer CL, Brennan JP, Slavin JL, Blick T, Thompson EW, Williams ED. 2006. Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Cancer Res. 66(23):11271–11278. doi: 10.1158/0008-5472.CAN-06-2044
  • Chaffer CL, Marjanovic ND, Lee T, Bell G, Kleer CG, Reinhardt F, D'Alessio AC, Young RA, Weinberg RA. 2013. Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell. 154(1):61–74. doi: 10.1016/j.cell.2013.06.005
  • Chaffer CL, Weinberg RA. 2011. A perspective on cancer cell metastasis. Science. 331:1559–1564. doi: 10.1126/science.1203543
  • Chambers AF, Groom AC, MacDonald IC. 2002. Macdonald dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2:563–572. doi: 10.1038/nrc865
  • Chao YC, Pan SH, Yang SC, Yu SL, Che TF, Lin CW, Tsai MS, Chang GC, Wu CH, Wu YY, Lee YC. 2009. Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma. Am J Respir Crit Care Med. 179(2):123–133. doi: 10.1164/rccm.200803-456OC
  • Chen CZ, Li L, Lodish HF, Bartel DP. 2004. MicroRNAs modulate hematopoietic lineage differentiation. Science. 303:83–86. doi: 10.1126/science.1091903
  • Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M. 2005. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA. 102:13944–13949. doi: 10.1073/pnas.0506654102
  • Coussens LM, Fingleton B, Matrisian LM. 2002. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science. 295:2387–2392. doi: 10.1126/science.1067100
  • Croce CM, Calin GA. 2005. miRNAs, cancer, and stem cell division. Cell. 122:6–7. doi: 10.1016/j.cell.2005.06.036
  • Croset M, Goehrig D, Frackowiak A, Bonnelye E, Ansieau S, Puisieux A, Clézardin P. 2014. TWIST1 expression in breast cancer cells facilitates bone metastasis formation. J BoneMiner Res. 29:1886–1899. doi: 10.1002/jbmr.2215
  • Dalmay T, Edwards DR. 2006. MicroRNAs and the hallmarks of cancer. Oncogene. 25:6170–6175. doi: 10.1038/sj.onc.1209911
  • De Craene B, Van Roy F, Berx G. 2005. Unraveling signalling cascades for the Snail family of transcription factors. Cell Signal. 17(5):535–547. doi: 10.1016/j.cellsig.2004.10.011
  • Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, Dedhar S. 1998. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci. 95(19):11211–11216. doi: 10.1073/pnas.95.19.11211
  • Dolmetsch RE, Xu K, Lewis RS. 1998. Calcium oscillations increase the efficiency and specificity of gene expression. Nature. 392:933–936. doi: 10.1038/31960
  • Dong C, Wilhelm D, Koopman P. 2004. Sox genes and cancer. Cytogenetic Genome Res. 105:442–447. doi: 10.1159/000078217
  • Dourdin N, Bhatt AK, Dutt P, Greer PA, Arthur JS, Elce JS, Huttenlocher A. 2001. Reduced cell migration and disruption of the actin cytoskeleton in calpain-deficient embryonic fibroblasts. J Biol Chem. 276:48382–48388.
  • Dufour A, Overall CM. 2013. Missing the target: matrix metalloproteinase antitargets in inflammation and cancer. Trends Pharmacol Sci. 34:233–242. doi: 10.1016/j.tips.2013.02.004
  • Eddy RJ, Pierini LM, Matsumura F, Maxfield FR. 2000. Ca2+-dependent myosin II activation is required for uropod retraction during neutrophil migration. J Cell Sci. 113:1287–1298.
  • Edme N, Downward J, Thiery JP, Boyer B. 2002. Ras induces NBT-II epithelial cell scattering through the coordinate activities of Rac and MAPK pathways. J Cell Sci. 115:2591–2601.
  • Eger A, Mikulits W. 2005. Models of epithelial–mesenchymal transition. Drug Discov Today Dis Models. 2:57–63. doi: 10.1016/j.ddmod.2005.04.001
  • Eriksson JE, Dechat T, Grin B, Helfand B, Mendez M, Pallari HM, Goldman RD. 2009. Introducing intermediate filaments: from discovery to disease. J Clin Invest, 119:1763–1771. doi: 10.1172/JCI38339
  • Fan K, Li D, Zhang Y, Han C, Liang J, Hou C, Xiao H, Ikenaka K, Ma J. 2015. The induction of neuronal death by up-regulated microglial cathepsin H in LPS-induced neuroinflammation. J Neuroinflammation. 12(1):1. doi: 10.1186/s12974-015-0268-x
  • Fanger CM, Hoth M, Crabtree GR, Lewis RS. 1995. Characterization of T cell mutants with defects in capacitative calcium entry: genetic evidence for the physiological roles of CRAC channels. J Cell Biol. 131:655–667. doi: 10.1083/jcb.131.3.655
  • Farady CJ, Sun J, Darragh MR, Miller SM, Craik CS. 2007. The mechanism of inhibition of antibody-based inhibitors of membrane-type serine protease 1 (MT-SP1). J Mol Biol. 369:1041–1051. doi: 10.1016/j.jmb.2007.03.078
  • Feske S, Gwack Y, Prakriya M, Srikanth S, Puppel SH, Tanasa B, Hogan PG, Lewis RS, Daly M, Rao A. 2006. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature. 441:179–185. doi: 10.1038/nature04702
  • Feske S, Prakriya M, Rao A, Lewis RS. 2005. A severe defect in CRAC Ca2+ channel activation and altered K+ channel gating in T cells from immunodeficient patients. J Exp Med. 202:651–662. doi: 10.1084/jem.20050687
  • Fidler IJ. 2003. The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer. 3, 453–458. doi: 10.1038/nrc1098
  • Fingleton B. 2008. MMPs as therapeutic targets—still a viable option? Semin Cell Dev Biol. 19:61–68. doi: 10.1016/j.semcdb.2007.06.006
  • Friedman RC, Farh KK, Burge CB, Bartel DP. 2008. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19:92–105. doi: 10.1101/gr.082701.108
  • Fukumoto S, Hsieh CM, Maemura K, Layne MD, Yet SF, Lee KH, Matsui T, Rosenzweig A, Taylor WG, Huttenlocher A, Palecek SP, et al. 1997. Regulation of cell migration by the calcium-dependent protease calpain. J. Biol. Chem. 272:32719–32722. doi: 10.1074/jbc.272.21.13816
  • Galkin AV, Mullen L, Fox WD, Brown J, Duncan D, Moreno O, Madison EL, Agus DB. 2004. CVS-3983, a selective matriptase inhibitor, suppresses the growth of androgen independent prostate tumour xenografts. Prostate. 61:228–235. doi: 10.1002/pros.20094
  • Goldman RD, Khuon S, Chou YH, Opal P, Steinert PM. 1996. The function of intermediate filaments in cell shape and cytoskeletal integrity. J Cell Biol. 134:971–983. doi: 10.1083/jcb.134.4.971
  • Gonzalez de Castro D, Clarke PA, Al-Lazikani B, Workman P. 2013. Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance. Clin Pharmacol Ther. 93(3):252–259. doi: 10.1038/clpt.2012.237
  • Gregory SG, Barlow KF, McLay KE, Kaul R, Swarbreck D, Dunham A, Scott CE, Howe KL, Woodfine K, Spencer CC, et al. 2006. The DNA sequence and biological annotation of human chromosome 1. Nature. 441:315–321. doi: 10.1038/nature04727
  • Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ. 2008. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601. doi: 10.1038/ncb1722
  • Grille SJ, Bellacosa A, Upson J, Klein-Szanto AJ, van Roy F, Lee-Kwon W, Donowitz M, Tsichlis PN, Larue L. 2003. The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res. 63:2172–2178.
  • Gupta GP, Massagué J. 2006. Cancer metastasis: building a framework. Cell. 127(4):679–695. doi: 10.1016/j.cell.2006.11.001
  • Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell. 100:57–70. doi: 10.1016/S0092-8674(00)81683-9
  • Humphries B, Wang Z, Oom AL, Fisher T, Tan D, Cui Y, Jiang Y, Yang C. 2014. MicroRNA-200b targets protein kinase C and suppresses triple-negative breast cancer metastasis. Carcinogenesis. 35:2254–2263. doi: 10.1093/carcin/bgu133
  • Hüsemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E, Forni G, Eils R, Fehm T, Riethmüller G, Klein CA. 2008. Systemic spread is an early step in breast cancer. Cancer Cell. 13(1):58–68. doi: 10.1016/j.ccr.2007.12.003
  • Huttenlocher A, Horwitz AR. 2011. Integrins in cell migration. CSH Perspect Biol. 3(9):a005074.
  • Ilic D, Furuta Y, Kanazawa S, Takeda N, Sobue K, Nakatsuji N, Nomura S, Fujimoto J, Okada M, Yamamoto T. 1995. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature. 377:539–544. doi: 10.1038/377539a0
  • Iliopoulos D, Lindahl-Allen M, Polytarchou C, Hirsch HA, Tsichlis PN, Struhl K. 2010. Loss of miR-200 inhibition of SUZ12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells. Mol Cell. 39:761–772. doi: 10.1016/j.molcel.2010.08.013
  • Jain RK. 2005. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science. 307:58–62. doi: 10.1126/science.1104819
  • Jakowlew SB. 2006. Transforming growth factor-beta in cancer and metastasis. Caner Metastasis Rev. 25:435–457. doi: 10.1007/s10555-006-9006-2
  • Jevnikar Z, Rojnik M, Jamnik P, Doljak B, Fonovic UP, Kos J. 2013. Cathepsin H mediates the processing of talin and regulates migration of prostate cancer cells. J Biol Chem. 288:2201–2209. doi: 10.1074/jbc.M112.436394
  • Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D, Slack FJ. 2005. RAS is regulated by the let-7 microRNA family. Cell. 120:635–647. doi: 10.1016/j.cell.2005.01.014
  • Kamachi Y, Kondoh H. 2013. Sox proteins: regulators of cell fate specification and differentiation. Development. 140:4129–4144. doi: 10.1242/dev.091793
  • Kang Y, Massagué J. 2004. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell. 118(3):277–279. doi: 10.1016/j.cell.2004.07.011
  • Kassis J, Lauffenburger DA, Turner T, Wells A. 2001. Semin. Cancer Biol. 11:105–117. doi: 10.1006/scbi.2000.0362
  • Katsumoto T, Mitsushima A, Kurimura T. 1990. The role of the vimentin intermediate filaments in rat 3Y1 cells elucidated by immunoelectron microscopy and computer-graphic reconstruction. Biol Cell. 68:139–146. doi: 10.1016/0248-4900(90)90299-I
  • Keller JM, Schade GR, Ives K, Cheng X, Rosol TJ, Piert M, Siddiqui J, Roberts WW, Keller ET. 2013. A novel canine model for prostate cancer. Prostate. 73:952–959. doi: 10.1002/pros.22642
  • Khan MN, Bhattacharyya T, Andrikopoulos P, Esteban MA, Barod R, Connor T, Ashcroft M, Maxwell PH, Kiriakidis S. 2011. Factor inhibiting HIF (FIH-1) promotes renal cancer cell survival by protecting cells from HIF-1α-mediated apoptosis. Brit J Cancer. 104(7):1151–1159. doi: 10.1038/bjc.2011.73
  • Kim S, Lee UJ, Kim MN, Lee EJ, Kim JY, Lee MY, Choung S, Kim YJ, Choi Y-C. 2008. MicroRNA miR-199a* regulates the MET proto-oncogene and the downstream extracellular signal-regulated kinase 2 (ERK2). J Biol Chem. 283:18158–18166. doi: 10.1074/jbc.M800186200
  • Kim YJ, Ahn JY, Liang P, Ip C, Zhang Y, Park YM. 2007. Human prx1 gene is a target of Nrf2 and is up-regulated by hypoxia/reoxygenation: implication to tumor biology. Cancer Res. 67:546–554. doi: 10.1158/0008-5472.CAN-06-2401
  • Kim AH, Khursigara G, Sun X, Franke TF, Chao MV. 2001. Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol Cell Biol. 21(3):893–901. doi: 10.1128/MCB.21.3.893-901.2001
  • Kim T, Veronese A, Pichiorri F, Lee TJ, Jeon YJ, Volinia S, Pineau P, Marchio A, Palatini J, Suh SS, et al. 2011. P53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J Exp Med. 208:875–883. doi: 10.1084/jem.20110235
  • Klein R. 2001. Excitatory Eph receptors and adhesive ephrin ligands. Curr Opin Cell Biol. 13(2):196–203. doi: 10.1016/S0955-0674(00)00197-6
  • Kleinerman DI, Troncoso P, Lin SH, Pisters LL, Sherwood ER, Brooks T, von Eschenbach AC, Hsieh JT. 1995. Consistent expression of an epithelial cell adhesion molecule (C-CAM) during human prostate development and loss of expression in prostate cancer: implication as a tumor suppressor. Cancer Res. 55(6):1215–1220.
  • Korpal M, Ell BJ, Buffa FM, Ibrahum T, Blanco MA, Celia-Terrassa T, Mercatali L, Khan Z, Goodarzi H, Hua Y, et al. 2011. Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat Med. 17:1101–1108. doi: 10.1038/nm.2401
  • Komuro H, Rakic P. 1993. Modulation of neuronal migration by NMDA receptors. Science. 260:95–95. doi: 10.1126/science.8096653
  • Krueger S, Kalinski T, Hundertmark T, Wex T, Küster D, Peitz U, Ebert M, Nägler DK, Kellner U, Malfertheiner P, et al. 2005. Up-regulation of cathepsin X in helicobacter pylori gastritis and gastric cancer. J Pathol. 207:32–42. doi: 10.1002/path.1820
  • Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. 2002. Identification of tissue-specific microRNAs from mouse. Curr Biol. 12:735–739. doi: 10.1016/S0960-9822(02)00809-6
  • Lawson MA, Maxfield FR. 1995. Ca2+ and calcineurin-dependent recycling of an integrin to the front of migrating neutrophils. Nature. 377:75–79. doi: 10.1038/377075a0
  • Leader M, Collins M, Patel J, Henry K. 1987. Vimentin: an evaluation of its role as a tumour marker. Histopathology. 11:63–72. doi: 10.1111/j.1365-2559.1987.tb02609.x
  • Leber MF, Efferth T. 2009. Molecular principles of cancer invasion and metastasis. Int J Oncol. 34:881–895.
  • Lee J, Ishihara A, Oxford G, Johnson B, Jacobson K. 1999. Regulation of cell movement is mediated by stretch-activated calcium channels. Nature. 400:382–386. doi: 10.1038/22578
  • Lee MK, Pardoux C, Hall MC, Lee PS, Warburton D, Qing J, Smith SM, Derynck R. 2007. TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J. 26:3957–3967. doi: 10.1038/sj.emboj.7601818
  • Leland ES, Wright PK. 2006. Resonance tuning of piezoelectric vibration energy scavenging generators using compressive axial preload. Smart Mater Struct. 15(5):1413–1420. doi: 10.1088/0964-1726/15/5/030
  • Leelawat K, Leelawat S, Tepaksorn P, Rattanasinganchan P, Leungchaweng A, Tohtong R, Sobhon P. 2006. Involvement of c-Met/hepatocyte growth factor pathway in cholangiocarcinoma cell invasion and its therapeutic inhibition with small interfering RNA specific for c-Met. J Surg Res. 136:78–84. doi: 10.1016/j.jss.2006.05.031
  • Lesnikoff N, Attema JL, Roslan S, Bert AG, Schwarz QP, Gregory PA, Goodall GJ. 2014. Specificity protein 1 (Sp1) maintains basal epithelial expression of the miR-200 family: implications for epithelial–mesenchymal transition. J Biol Chem. 289:11194–11205. doi: 10.1074/jbc.M113.529172
  • Lewis RS. 2007. The molecular choreography of a store-operated calcium channel. Nature. 446:284–287. doi: 10.1038/nature05637
  • Lewis RS. 2001. Calcium signaling mechanisms in T lymphocytes. Annu Rev Immunol. 19:497–521. doi: 10.1146/annurev.immunol.19.1.497
  • Lewis BP, Burge CB, Bartel DP. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 120:15–20. doi: 10.1016/j.cell.2004.12.035
  • Li P, Jiang S, Lee SL, Lin CY, Johnson MD, Dickson RB, Michejda CJ, Roller PP. 2007. Design and synthesis of novel and potent inhibitors of the type II transmembrane serine protease, matriptase, based upon the sunflower trypsin inhibitor-1. J Med Chem. 50:5976–5983. doi: 10.1021/jm0704898
  • Li R, Liang J, Ni S, Zhou T, Qing X, Li H, He W, Chen J, Li F, Zhuang Q, Qin B. 2010. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell. 7(1):51–63. doi: 10.1016/j.stem.2010.04.014
  • Li X, Pei D, Zheng H. 2014. Transitions between epithelial and mesenchymal states during cell fate conversions. Protein Cell. 5(8):580–591. doi: 10.1007/s13238-014-0064-x
  • Li X, Roslan S, Johnstone CN, Wright JA, Bracken CP, Anderson M, Bert AG, Selth LA, Anderson RL, Goodall GJ, et al. 2014. MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways. Oncogene. 33:4077–4088. doi: 10.1038/onc.2013.370
  • Li G, Shrotriya V, Huang J, Yao Y, Moriarty T, Emery K, Yang Y. 2005. High-efficiency solution processable polymer photovoltaic cells by self-organization of polymer blends. Nat Mater. 4(11):864–868. doi: 10.1038/nmat1500
  • Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM. 2005. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 433:769–773. doi: 10.1038/nature03315
  • Lim LP, Lau NC, Weinstein EG, Abdelhakim A, Yekta S, Rhoades MW, Burge CB, Bartel DP. 2003. The microRNAs of Caenorhabditis elegans. Genes Dev. 17:991–1008. doi: 10.1101/gad.1074403
  • Lin SL, Chiang A, Chang D, Ying SY. 2008. Loss of mir-146a function in hormone-refractory prostate cancer. RNA. 14:417–424. doi: 10.1261/rna.874808
  • Lin CY, Tseng IC, Chou FP, Su SF, Chen YW, Johnson MD, Dickson RB. 2008. Zymogen activation, inhibition, and ectodomain shedding of matriptase. Front Biosci. 13:621–635. doi: 10.2741/2707
  • Linder S. 2009. Invadosomes at a glance. J Cell Sci. 122(17):3009–3013. doi: 10.1242/jcs.032631
  • Liou J, Kim ML, Do Heo W, Jones JT, Myers JW, Ferrell JE, Meyer T. 2005. STIM is a Ca2+ sensor essential for Ca2+-store-depletion-triggered Ca2+ influx. Curr Biol. 15(13):1235–1241. doi: 10.1016/j.cub.2005.05.055
  • List K. 2009. Matriptase: a culprit in cancer? Future Oncol. 5:97–104. doi: 10.2217/14796694.5.1.97
  • List K, Bugge TH, Szabo R. 2006. Matriptase: potent proteolysis on the cell surface. Mol Med. 12:1–7. doi: 10.2119/2006-00022.List
  • Liu H, Wang S, Sun H, Pan Z, Zhou W, Wu M. 2010. Inhibition of tumorigenesis and invasion of hepatocellular carcinoma by siRNA mediated silencing of the livin gene. Mol Med Report. 3:903–907.
  • Liu Z, Zhang B, Liu K, Ding Z, Hu X. 2012. Schisandrin B attenuates cancer invasion and metastasis via inhibiting epithelial-mesenchymal transition. PLoS ONE. 7(7):e40480. doi: 10.1371/journal.pone.0040480
  • Ma L, Teruya-Feldstein J, Weinberg RA. 2007. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 449(7163):682–688. doi: 10.1038/nature06174
  • Ma PC, Tretiakova MS, Nallasura V, Jagadeeswaran R, Husain AN, Salgia R. 2007. Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumour invasion. Br J Cancer. 97:368–377. doi: 10.1038/sj.bjc.6603884
  • Mallini P, Lennard T, Kirby J, Meeson A. 2014. Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance. Cancer Treat Rev. 40(3):341–348. doi: 10.1016/j.ctrv.2013.09.008
  • Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL. 2008. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 133(4):704–715. doi: 10.1016/j.cell.2008.03.027
  • Marks PW, Maxfield FR. 1990. Transient increases in cytosolic free calcium appear to be required for the migration of adherent human neutrophils. J. Cell Biol. 110:43–52. doi: 10.1083/jcb.110.1.43
  • McKenzie JA, Liu T, Jung JY, Jones BB, Ekiz HA, Welm AL, Grossman D. 2013. Survivin promotion of melanoma metastasis requires upregulation of α5 integrin. Carcinogenesis. 34(9):2137–2144. doi: 10.1093/carcin/bgt155
  • Mehlen P, Puisieux A. 2006. Metastasis: a question of life or death. Nat Rev Cancer. 6:449–458. doi: 10.1038/nrc1886
  • Mercer JC, Dehaven WI, Smyth JT, Wedel B, Boyles RR, Bird GS, Putney Jr, JW. 2006. Large store-operated calcium selective currents due to co-expression of Orai1 or Orai2 with the intracellular calcium sensor, Stim1. J Biol Chem, 281:24979–24990. doi: 10.1074/jbc.M604589200
  • Michael MZ, O’Connor SM, van Holst Pellekaan NG, Young GP, James RJ. 2003. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res. 1:882–891.
  • Mogami H, Nakano K, Tepikin AV, Petersen OH. 1997. Ca2+ flow via tunnels in polarized cells: recharging of apical Ca2+ stores by focal Ca2+ entry through basal membrane patch. Cell. 88:49–55. doi: 10.1016/S0092-8674(00)81857-7
  • Morel AP, Lièvre M, Thomas C, Hinkal G, Ansieau S, Puisieux A. 2008. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PloS one. 3(8):e2888. doi: 10.1371/journal.pone.0002888
  • Musiyenko A, Bitko V, Barik S. 2008. Ectopic expression regulates protein translation and invasiveness of prostate cancer LNCaP cells. J Mol Med. 86:313–322. doi: 10.1007/s00109-007-0296-9
  • Nakajima Y, Yamagishi T, Hokari S, Nakamura H. 2000. Mechanisms involved in valvuloseptal endocardial cushion formation in early cardiogenesis: roles of transforming growth factor (TGF)-beta and bone morphogenetic protein (BMP). Anat Rec, 258:119–145. doi: 10.1002/(SICI)1097-0185(20000201)258:2<119::AID-AR1>3.0.CO;2-U
  • Nakaya Y, Kuroda S, Katagiri YT, Kaibuchi K, Takahashi Y. 2004. Mesenchymal–epithelial transition during somitic segmentation is regulated by differential roles of Cdc42 and Rac1. Dev Cell. 7:425–438. doi: 10.1016/j.devcel.2004.08.003
  • Napp J, Dullin C, Muller F, Uhland K, Petri JB, van de Locht A, Steinmetzer T, Alves F. 2010. Time-domain in vivo near infrared fluorescence imaging for evaluation of matriptase as a potential target for the development of novel, inhibitor-based tumour therapies. Int J Cancer. 127:1958–1974. doi: 10.1002/ijc.25405
  • Nishiyama M, Hoshino A, Tsai L, Henley JR, Goshima Y, Tessier-Lavigne M, Poo MM, Hong K. 2003. Cyclic AMP/GMP-dependent modulation of Ca2+ channels sets the polarity of nerve growth-cone turning. Nature. 423, 990–995. doi: 10.1038/nature01751
  • Novak A, Hsu SC, Leung-Hagesteijn C, Radeva G, Papkoff J, Montesano R, Roskelley C, Grosschedl R, Dedhar S. 1998. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and β-catenin signaling pathways. Proc Natl Acad Sci USA. 95:4374–4379. doi: 10.1073/pnas.95.8.4374
  • Ocaña OH, Córcoles R, Fabra Á, Moreno-Bueno G, Acloque H, Vega S, Barrallo-Gimeno A, Cano A, Nieto MA. 2012. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell. 22(6):709–724. doi: 10.1016/j.ccr.2012.10.012
  • Palmer HG, Larriba MJ, Garcia JM, Ordonez-Moran P, Pena C, Peiro S, Puig I, Rodriguez R, de la Fuente R, Bernad A, et al. 2004. Nat Med. 10:917–919. doi: 10.1038/nm1095
  • Parekh AB, Penner R. 1997. Store depletion and calcium influx. Physiol Rev. 7:901–930.
  • Park SM, Gaur AB, Lengyel E, Peter ME. 2008. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 22:894–907. doi: 10.1101/gad.1640608
  • Park HS, Kim MS, Huh SH, Park J, Chung J, Kang SS, Choi EJ. 2002. Akt (protein kinase B) negatively regulates SEK1 by means of protein phosphorylation. J Biol Chem. 277(4):2573–2578. doi: 10.1074/jbc.M110299200
  • Park CY, Kim DK, Sheen YY. 2011. EW-7203, a novel small molecule inhibitor of transforming growth factor-ß (TGF-ß) type I receptor/activin receptor/like kinase-5, blocks TGF-ß1- mediated epithelial-to-mesenchymal transition in mammary epithelial cells. Cancer Sci. 102:1889–1896. doi: 10.1111/j.1349-7006.2011.02014.x
  • Parkin DM, Bray F, Ferlay J, Pisani P. 2005. Global cancer statistics. CA Cancer J Clin. 55:74–108. doi: 10.3322/canjclin.55.2.74
  • Patrussi L, Baldari CT. 2011. The CXCL12/CXCR4 axis as a therapeutic target in cancer and HIV-1 infection. Curr Med Chem. 18(4):497–512. doi: 10.2174/092986711794480159
  • Pavlaki M, Zucker S. 2003. Matrix metalloproteinase inhibitors (MMPIs): the beginning of phase I or the termination of phase III clinical trials. Cancer Metastasis Rev. 22:177–203. doi: 10.1023/A:1023047431869
  • Pavlaki M, Zucker S, Dufour A, Calabrese N, Bahou W, Cao J. 2010. Furin functions as a nonproteolytic chaperone for matrix metalloproteinase-28: MMP-28 propeptide sequence requirement. Biochem res int. 2011. doi:10.1155/2011/630319.
  • Peinelt C, Vig M, Koomoa DL, Beck A, Nadler MJ, Koblan-Huberson M, Lis A, Fleig A, Penner R, Kinet JP. 2006. Amplification of CRAC current by STIM1 and CRACM1 (Orai1). Nat Cell Biol. 8:771–773. doi: 10.1038/ncb1435
  • Pettit EJ, Fay FS. 1998. Cytosolic free calcium and the cytoskeleton in the control of leukocyte chemotaxis. Physiol Rev. 78:949–967.
  • Pillai RS. 2005. MicroRNA function: multiple mechanisms for a tiny RNA? RNA. 11:1753–1761. doi: 10.1261/rna.2248605
  • Prakriya M, Feske S, Gwack Y, Srikanth S, Rao A, Hogan PG. 2006. Orai1 is an essential pore subunit of the CRAC channel. Nature. 443:230–233. doi: 10.1038/nature05122
  • Pruitt FL, He Y, Franco OE, Jiang M, Cates JM, Hayward SW. 2013. Cathepsin D acts as an essential mediator to promote malignancy of benign prostatic epithelium. Am J Pathol. 73:476–488.
  • Quintanilla-Dieck MJ, Codriansky K, Keady M, Bhawan J, Rünger TM. 2008. Cathepsin K in melanoma invasion. J Invest Dermatol. 128:2281–2288. doi: 10.1038/jid.2008.63
  • Radisky DC, Levy DD, Littlepage LE, Liu H, Nelson CM, Fata JE, Leake D, Godden EL, Albertson DG, Nieto MA, et al. 2005. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature. 436:123–127. doi: 10.1038/nature03688
  • Ren XD, Kiosses WB, Sieg DJ, Otey CA, Schlaepfer DD, Schwartz MA. 2000. Focal adhesion kinase suppresses Rho activity to promote focal adhesion turnover. J Cell Sci. 113:3673–3678.
  • Ren G, Tian Q, An Y, Feng B, Lu Y, Liang J, Li K, Shang Y, Nie Y, Wang X, Fan D. 2012. Coronin 3 promotes gastric cancer metastasis via the up-regulation of MMP-9 and cathepsin K. Mol Cancer. 11:67. doi: 10.1186/1476-4598-11-67.
  • Roos J, DiGregorio PJ, Yeromin AV, Ohlsen K, Lioudyno M, Zhang S, Safrina O, Kozak JA, Wagner SL, Cahalan MD, Veliçelebi G. 2005. STIM1, an essential and conserved component of store-operated Ca2+ channel function. J Cell Biol. 169(3):435–445. doi: 10.1083/jcb.200502019
  • Samavarchi-Tehrani P, Golipour A, David L, Sung HK, Beyer TA, Datti A, Woltjen K, Nagy A, Wrana JL. 2010. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell. 7(1):64–77. doi: 10.1016/j.stem.2010.04.015
  • Sarkar A, Hochedlinger K. 2013. The sox family of transcription factors: versatile regulators of stem and progenitor cell fate. Cell Stem Cell. 12:15–30. doi: 10.1016/j.stem.2012.12.007
  • Saunders LR, McClay DR. 2014. Sub-circuits of a gene regulatory network control a developmental epithelial-mesenchymal transition. Development. 141:1503–1513. doi: 10.1242/dev.101436
  • Sela-Passwell N, Trahtenherts A, Kruger A, Sagi I. 2011. New opportunities in drug design of metalloproteinase inhibitors: combination between structure–function experimental approaches and systems biology. Expert Opin Drug Discov. 6:527–542. doi: 10.1517/17460441.2011.560936
  • Sengupta S, den Boon JA, Chen IH, Newton MA, Stanhope SA, Cheng YJ, Chen C-J, Hildesheim A, Sugden B, Ahlquist P. 2008. MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc Natl Acad Sci USA. 105:5874–5878. doi: 10.1073/pnas.0801130105
  • Senol O, Schaaij-Visser TBM, Erkan EP, Dorfer C, Lewandrowski G, Pham TV, Piersma SR, Peerdeman SM, Ströbel T, Tannous B, et al. 2014. miR-200a-mediated suppression of non-muscle heavy chain IIb inhibits meningioma cell migration and tumor growth in vivo. Oncogene. 120(14):1790–1798.
  • Shen X, Wang S, Wang H, Liang M, Xiao L, Wang Z. 2009. The role of SDF-1/ CXCR4 axis in ovarian cancer metastasis. J Huazhong Univ Sci Technol Med Sci. 29:363–367. doi: 10.1007/s11596-009-0320-0
  • Shi YE, Torri J, Yieh L, Wellstein A, Lippman ME, Dickson RB. 1993. Identification and characterization of a novel matrix-degrading protease from hormone-dependent human breast cancer cells. Cancer Res. 53:1409–1415.
  • Shimono Y, Zabala M, Cho RW, Lobo N, Dalerba P, Qian D, Diehn M, Liu H, Panula SP, Chiao E, Dirbas FM. 2009. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell. 138(3):592–603. doi: 10.1016/j.cell.2009.07.011
  • Siciliano JC, Toutant M, Derkinderen P, Sasaki T, Girault JA. 1996. Differential regulation of proline-rich tyrosine kinase 2/cell adhesion kinase beta (PYK2/CAKbeta) and pp125(FAK) by glutamate and depolarization in rat hippocampus. J Biol Chem. 271:28942–28946. doi: 10.1074/jbc.271.46.28942
  • Siegel R, Ma J, Zou Z, Jemal A. 2014. Cancer statistics. CA Cancer J Clin. 64: 9–29 doi: 10.3322/caac.21208
  • Sipeki S, Bander E, Buday L, Farkas G, Bácsy E, Ways DK, Faragó A. 1999. Phosphatidylinositol 3-kinase contributes to Erk1/Erk2 MAP kinase activation associated with hepatocyte growth factor-induced cell scattering. Cell Signal. 11:885–890. doi: 10.1016/S0898-6568(99)00060-1
  • Soboloff J, Spassova MA, Tang XD, Hewavitharana T, Xu W, Gill DL. 2006. Orai1 and STIM reconstitute store-operated calcium channel function. J Biol Chem. 281:20661–20665. doi: 10.1074/jbc.C600126200
  • Sonoshita M, Aoki M, Fuwa H, Aoki K, Hosogi H, Sakai Y, Hasida H, Takabayashi A, Sasaki M, Robine S, et al. 2011. Suppression of colon cancer metastasis by Aes through inhibition of notch signaling. Cancer Cell. 19:125–137. doi: 10.1016/j.ccr.2010.11.008
  • Staal SP. 1987. Proc Natl Acad Sci USA. 84:5034–5037. doi: 10.1073/pnas.84.14.5034
  • Steeg PS. 2006. Tumour metastasis: mechanistic insights and clinical challenges. Nat Med. 12:895–904. doi: 10.1038/nm1469
  • Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, Suyama A, Sugano S. 1997. Construction and characterization of a full length-enriched and a 5′-end-enriched cDNA library. Gene. 200:149–156. doi: 10.1016/S0378-1119(97)00411-3
  • Tan C, Costello P, Sanghera J, Dominguez D, Baulida J, de Herreros AG, Dedhar S. 2001. Inhibition of integrin linked kinase (ILK) suppresses b-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC−/− human colon carcinoma cells. Oncogene. 20:133–140. doi: 10.1038/sj.onc.1204052
  • Tarver T. 2012. Cancer Facts & Figures 2012. American Cancer Society (ACS) Atlanta, GA: American Cancer Society, 2012. J Consum Health Internet. 16(3):366–367. doi: 10.1080/15398285.2012.701177
  • Tavazoie SF, Alarcón C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL, Massagué J. 2008. Endogenous human microRNAs that suppress breast cancer metastasis. Nature. 451:147–152. doi: 10.1038/nature06487
  • Testa JR, Bellacosa A. 2001. Proc Natl Acad Sci USA. 98:10983–10985. doi: 10.1073/pnas.211430998
  • Thiery JP. 2002. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2:442–454. doi: 10.1038/nrc822. PMID 12189386.
  • Thiery JP, Acloque H, Huang RYJ, Nieto MA. 2009. Epithelial–mesenchymal transitions in development and disease. Cell. 139(5):871–890. doi: 10.1016/j.cell.2009.11.007
  • Thiery JP, Morgan M. 2004. Breast cancer progression with a Twist. Nat med. 10(8):777–778. doi: 10.1038/nm0804-777
  • Thompson NL, Lin SH, Panzica MA, Hixson DC. 1994. Cell CAM 105 isoform RNA expression is differentially regulated during rat liver regeneration and carcinogenesis. Pathobiology. 62(4):209–220. doi: 10.1159/000163912
  • Thompson EW, Newgreen DF. 2005. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res. 65(14):5991–5995. doi: 10.1158/0008-5472.CAN-05-0616
  • Thorgeirsson SS, Grisham JW. 2002. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet. 31:339–346. doi: 10.1038/ng0802-339
  • Tian Q, Feetham MC, Tao WA, He XC, Li L, Aebersold R, Hood L. 2004. Proteomic analysis identifies that 14-3-3zeta interacts with beta-catenin and facilitates its activation by Akt. Proc Natl Acad Sci USA. 101:15370–15375. doi: 10.1073/pnas.0406499101
  • Timmerman LA, Grego-Bessa J, Raya A, Bertran E, Perez-Pomares JM, Diez J, Aranda S, Palomo S, McCormick F, Izpisua-Belmonte JC, de la Pompa JL. 2004. Notch promotes epithelial–mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev. 18:99–115. doi: 10.1101/gad.276304
  • Tsai JH, Donaher JL, Murphy DA, Chau S, Yang J. 2012. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell. 22(6):725–736. doi: 10.1016/j.ccr.2012.09.022
  • Van Dusen NJ, Firulli AB. 2012. Twist factor regulation of non-cardiomyocyte cell lineages in the developing heart. Differentiation. 84:79–88. doi: 10.1016/j.diff.2012.03.002
  • Veeraraghavalu K, Subbaiah VK, Srivastava S, Chakrabarti O, Syal R, Krishna S. 2005. Complementation of human papillomavirus type 16 E6 and E7 by Jagged1-specific Notch1-phosphatidylinositol 3-kinase signaling involves pleiotropic oncogenic functions independent of CBF1;Su(H);Lag-1 activation. J Virol. 79:7889–7898. doi: 10.1128/JVI.79.12.7889-7898.2005
  • Vig M, Peinelt C, Beck A, Koomoa DL, Rabah D, Koblan-Huberson M, Kraft S, Turner H, Fleig A, Penner R, Kinet JP. 2006. CRACM1 is a plasma membrane protein essential for store-operated Ca2+ entry. Science. 312(5777):1220–1223. doi: 10.1126/science.1127883
  • Vleminckx K, Vakaet Jr, L, Mareel M, Fiers W, van Roy F. 1991. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell. 66:107–119. doi: 10.1016/0092-8674(91)90143-M
  • Wang Z, Humphries B, Xiao H, Jiang Y, Yang C. 2014. MicroRNA-200b suppresses arsenic-transformed cell migration by targeting protein kinase Cα and Wnt5b protein kinase Cα-positive feedback loop and inhibiting Rac1 activation. J Biol Chem. 289:18373–18386. doi: 10.1074/jbc.M114.554246
  • Webb DJ, Donais K, Whitmore LA, Thomas SM, Turner CE, Parsons JT, Horwitz AF. 2004. FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol. 6:154–161. doi: 10.1038/ncb1094
  • Wegner SV, Arslan H, Sunbul M, Yin J, He C. 2010. Dynamic copper (I) imaging in mammalian cells with a genetically encoded fluorescent copper (I) sensor. J Am Chem Soc. 132(8):2567–2569. doi: 10.1021/ja9097324
  • Weihua Z, Tsan R, Huang WC, Wu Q, Chiu CH, Fidler IJ, Hung MC. 2008. Survival of cancer cells is maintained by EGFR independent of its kinase activity. Cancer Cell. 13(5):385–393. doi: 10.1016/j.ccr.2008.03.015
  • Wells A, Yates C, Shepard CR. 2008. E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. Clin Exp Metast. 25:621–628. doi: 10.1007/s10585-008-9167-1
  • Weston CR, Davis RJ. 2001. Signal transduction – signaling specificity – a complex affair. Science. 292:2439–2440. doi: 10.1126/science.1063279
  • Williams LV, Veliceasa D, Vinokour E, Volpert OV. 2013. miR-200b inhibits prostate cancer, EMT, growth and metastasis. PLoS ONE. 34(6):1735–1744.
  • Wissmüller S, Kosian T, Wolf M, Finzsch M, Wegner M. 2006. The high-mobility-group domain of Sox proteins interacts with DNA-binding domains of many transcription factors. Nucleic Acids Res. 34:1735–1744. doi: 10.1093/nar/gkl105
  • Wu C. 1999. Integrin-linked kinase and PINCH: partners in regulation of cell-extracellular matrix interaction and signal transduction. J Cell Sci. 112:4485–4489.
  • Wu C, Keightley SY, Leung-Hagesteijn C, Radeva G, Coppolino M, Goicoechea S, McDonald JA, Dedhar S. 1998. Integrin-linked protein kinase regulates fibronectin matrix assembly, E-cadherin expression, and tumorigenicity. J Biol Chem. 273(1):528–536. doi: 10.1074/jbc.273.1.528
  • Wu F, Yang LY, Li YF, Ou DP, Chen DP, Fan C. 2009. Novel role for epidermal growth factor-like domain 7 in metastasis of human hepatocellular carcinoma. Hepatology. 50:1839–1850. doi: 10.1002/hep.23197
  • Wyckoff JB, Wang Y, Lin EY, Li JF, Goswami S, Stanley ER, Segall JE, Pollard JW, Condeelis J. 2007. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res. 67:2649–2656. doi: 10.1158/0008-5472.CAN-06-1823
  • Xue G, Hemmings BA. 2012. Phosphorylation of basic helix-loop-helix transcription factor twist in development and disease. Biochem Soc Trans. 40:90–93. doi: 10.1042/BST20110678
  • Yang YL, Ju HZ, Liu SF, Lee TC, Shih YW, Chuang LY, Guh J-Y, Yang Y-Y, Liao T-N, Hung T-J, Hung M-Y. 2011. BMP-2 suppresses renal interstitial fibrosis by regulating epithelial–mesenchymal transition. J Cell Biochem. 112:2558–2565. doi: 10.1002/jcb.23180
  • Yang Y, Lim SK, Choong LY, Lee H, Chen Y, Chong PK, Ashktorab H, Wang TT, Salto-Tellez M, Yeoh KG, et al. 2010. Cathepsin S mediates gastric cancer cell migration and invasion via a putative network of metastasis-associated proteins. J Proteome Res. 9:4767–4778. doi: 10.1021/pr100492x
  • Yang Z, Rayala S, Nguyen D, Vadlamudi RK, Chen S, Kumar R. 2005. Pak1 phosphorylation of snail, a master regulator of epithelial-to-mesenchyme transition, modulates snail’s subcellular localization and functions. Cancer Res. 65:3179–3184.
  • Yang J, Weinberg RA. 2008. Epithelial-mesenchymal transition: at the crossroads of development and tumour metastasis. Dev Cell. 14:818–829. doi: 10.1016/j.devcel.2008.05.009
  • Yang MH, Wu MZ, Chiou SH, Chen PM, Chang SY, Liu CJ, Teng S-C, Wu K-J. 2008. Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol. 10:295–305. doi: 10.1038/ncb1691
  • Yeromin AV, Zhang SL, Jiang W, Yu Y, Safrina O, Cahalan MD. 2006. Cahalan molecular identification of the CRAC channel by altered ion selectivity in a mutant of Orai. Nature. 443:226–229. doi: 10.1038/nature05108
  • Yoo AS, Cheng I, Chung S, Grenfell TZ, Lee H, Pack-Chung E, Handler M, Shen J, Xia W, Tesco G, et al. 2000. Presenilin-mediated modulation of capacitative calcium entry. Neuron. 27:561–572. doi: 10.1016/S0896-6273(00)00066-0
  • Zamore PD, Haley B. 2005. Ribo-gnome: the big world of small RNAs. Science. 309:1519–1524. doi: 10.1126/science.1111444
  • Zhang L, Huang G, Li X, Zhang Y, Jiang Y, Shen J, Liu J, Wang Q, Zhu J, Feng X, et al. 2013. Hypoxia induces epithelial–mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor-1a in hepatocellular carcinoma. BMC Cancer. 13:444. doi: 10.1186/1471-2407-13-108. doi: 10.1186/1471-2407-13-444
  • Zhang K, Zhang S, Jiao X, Wang H, Zhang D, Niu Z, Shen Y, Lv L, Zhou Y. 2010. Slug regulates proliferation and invasiveness of esophageal adenocarcinoma cells in vitro and in vivo. Med Oncol. 28:1089–1100. doi: 10.1007/s12032-010-9652-7
  • Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo YY. 2008. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 18:350–359. doi: 10.1038/cr.2008.24
  • Zhang SL, Yeromin AV, Zhang XH, Yu Y, Safrina O, Penna A, Roos J, Stauderman KA, Cahalan MD. 2006. Genome-wide RNAi screen of Ca(2+) influx identifies genes that regulate Ca(2+) release-activated Ca(2+) channel activity. Proc Natl Acad Sci USA. 103(24):9357–9362. ( Export to RIS). doi: 10.1073/pnas.0603161103

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.